Melanoma Regression and Recurrence in Zebrafish

Area of Science:

• Oncology
• Genetics
• Developmental Biology

Background:

• Melanoma is an aggressive skin cancer with high mortality.
• BRAF (V600E) inhibitors are effective but often lead to drug resistance and tumor recurrence.
• The transcription factor MITF plays a key role in melanoma progression.

Purpose of the Study:

• To establish protocols for studying melanoma regression and recurrence in vivo.
• To investigate the mechanisms of drug resistance in melanoma.
• To analyze the role of MITF in melanoma tumor growth and regrowth.

Main Methods:

• Utilizing a temperature-sensitive zebrafish model of human melanoma.
• Implementing protocols for in vivo studies of tumor regression and recurrence.
• Employing histology and immunohistochemistry techniques.

Main Results:

• The study provides reproducible protocols for melanoma research.
• The zebrafish model allows for the observation of tumor dynamics.
• The role of MITF in melanoma recurrence is further elucidated.

Conclusions:

• The described protocols facilitate the study of melanoma drug resistance and recurrence.
• Understanding MITF's function is vital for overcoming treatment resistance.
• Zebrafish models offer a powerful platform for melanoma research.